The adaptation and validation of a stigma measure for individuals with multiple sclerosis

Elizabeth Devon Eldridge-Smith, Megan Loew, Lara M Stepleman

Research output: Contribution to journalArticle

Abstract

Purpose: Stigma negatively impacts quality of life for individuals with multiple sclerosis. Availability of instruments to assess levels of stigma are crucial for monitoring and targeted intervention. The study aims to adapt the Reece Stigma Scale for use with this specific population and examine its reliability and validity. Methods: The scale was administered the 137 participants included in a larger study on identity and multiple sclerosis. Validity was evaluated utilizing the Downing model, as well as assessing potentially related constructs, including adherence, depression, anxiety, quality of life, self-efficacy, and post-traumatic growth. Results: Principal component analysis revealed a one factor solution with excellent internal consistency. Additional construct support offered evidence that higher levels of stigma are related to lower adherence and self-management efficacy, higher levels of anxiety and depressive symptoms, as well as more dissatisfaction with quality of life. Conclusions: This study provides preliminary support for an adapted version of the Reece Stigma Scale, specific to the multiple sclerosis population. The validation data suggests strong psychometric properties. Our findings underscore the clinical importance of measuring and addressing stigma among these patients, with the potential to improve medical (i.e., adherence), psychological (i.e., depression and anxiety), and quality of life outcomes.Implications for rehabilitation Understanding stigma-related experiences is crucial to enhance psychosocial factors related to multiple sclerosis. Stigma-related experiences also impact disease treatment outcomes for individuals with multiple sclerosis. The Reece Stigma Scale is a valid and reliable measure of felt stigma created for use in HIV populations. This study adapted and validated the use of the scale among individuals with multiple sclerosis. Clinicians and researchers working within the rehabilitation and treatment area of multiple sclerosis may benefit from using the adapted Reece Stigma Scale to measure and address stigma experiences.

Original languageEnglish (US)
JournalDisability and Rehabilitation
DOIs
StatePublished - Jan 1 2019

Fingerprint

Multiple Sclerosis
Quality of Life
Anxiety
Depression
Rehabilitation
Psychology
Population
Self Efficacy
Self Care
Principal Component Analysis
Psychometrics
Reproducibility of Results
Research Personnel
HIV
Growth

Keywords

  • Multiple sclerosis
  • assessment
  • quality of life
  • stigma
  • validation

ASJC Scopus subject areas

  • Rehabilitation

Cite this

The adaptation and validation of a stigma measure for individuals with multiple sclerosis. / Eldridge-Smith, Elizabeth Devon; Loew, Megan; Stepleman, Lara M.

In: Disability and Rehabilitation, 01.01.2019.

Research output: Contribution to journalArticle

@article{4fabdba4d47a4602915cf7ea68ab9635,
title = "The adaptation and validation of a stigma measure for individuals with multiple sclerosis",
abstract = "Purpose: Stigma negatively impacts quality of life for individuals with multiple sclerosis. Availability of instruments to assess levels of stigma are crucial for monitoring and targeted intervention. The study aims to adapt the Reece Stigma Scale for use with this specific population and examine its reliability and validity. Methods: The scale was administered the 137 participants included in a larger study on identity and multiple sclerosis. Validity was evaluated utilizing the Downing model, as well as assessing potentially related constructs, including adherence, depression, anxiety, quality of life, self-efficacy, and post-traumatic growth. Results: Principal component analysis revealed a one factor solution with excellent internal consistency. Additional construct support offered evidence that higher levels of stigma are related to lower adherence and self-management efficacy, higher levels of anxiety and depressive symptoms, as well as more dissatisfaction with quality of life. Conclusions: This study provides preliminary support for an adapted version of the Reece Stigma Scale, specific to the multiple sclerosis population. The validation data suggests strong psychometric properties. Our findings underscore the clinical importance of measuring and addressing stigma among these patients, with the potential to improve medical (i.e., adherence), psychological (i.e., depression and anxiety), and quality of life outcomes.Implications for rehabilitation Understanding stigma-related experiences is crucial to enhance psychosocial factors related to multiple sclerosis. Stigma-related experiences also impact disease treatment outcomes for individuals with multiple sclerosis. The Reece Stigma Scale is a valid and reliable measure of felt stigma created for use in HIV populations. This study adapted and validated the use of the scale among individuals with multiple sclerosis. Clinicians and researchers working within the rehabilitation and treatment area of multiple sclerosis may benefit from using the adapted Reece Stigma Scale to measure and address stigma experiences.",
keywords = "Multiple sclerosis, assessment, quality of life, stigma, validation",
author = "Eldridge-Smith, {Elizabeth Devon} and Megan Loew and Stepleman, {Lara M}",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/09638288.2019.1617793",
language = "English (US)",
journal = "Disability and Rehabilitation",
issn = "0963-8288",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - The adaptation and validation of a stigma measure for individuals with multiple sclerosis

AU - Eldridge-Smith, Elizabeth Devon

AU - Loew, Megan

AU - Stepleman, Lara M

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose: Stigma negatively impacts quality of life for individuals with multiple sclerosis. Availability of instruments to assess levels of stigma are crucial for monitoring and targeted intervention. The study aims to adapt the Reece Stigma Scale for use with this specific population and examine its reliability and validity. Methods: The scale was administered the 137 participants included in a larger study on identity and multiple sclerosis. Validity was evaluated utilizing the Downing model, as well as assessing potentially related constructs, including adherence, depression, anxiety, quality of life, self-efficacy, and post-traumatic growth. Results: Principal component analysis revealed a one factor solution with excellent internal consistency. Additional construct support offered evidence that higher levels of stigma are related to lower adherence and self-management efficacy, higher levels of anxiety and depressive symptoms, as well as more dissatisfaction with quality of life. Conclusions: This study provides preliminary support for an adapted version of the Reece Stigma Scale, specific to the multiple sclerosis population. The validation data suggests strong psychometric properties. Our findings underscore the clinical importance of measuring and addressing stigma among these patients, with the potential to improve medical (i.e., adherence), psychological (i.e., depression and anxiety), and quality of life outcomes.Implications for rehabilitation Understanding stigma-related experiences is crucial to enhance psychosocial factors related to multiple sclerosis. Stigma-related experiences also impact disease treatment outcomes for individuals with multiple sclerosis. The Reece Stigma Scale is a valid and reliable measure of felt stigma created for use in HIV populations. This study adapted and validated the use of the scale among individuals with multiple sclerosis. Clinicians and researchers working within the rehabilitation and treatment area of multiple sclerosis may benefit from using the adapted Reece Stigma Scale to measure and address stigma experiences.

AB - Purpose: Stigma negatively impacts quality of life for individuals with multiple sclerosis. Availability of instruments to assess levels of stigma are crucial for monitoring and targeted intervention. The study aims to adapt the Reece Stigma Scale for use with this specific population and examine its reliability and validity. Methods: The scale was administered the 137 participants included in a larger study on identity and multiple sclerosis. Validity was evaluated utilizing the Downing model, as well as assessing potentially related constructs, including adherence, depression, anxiety, quality of life, self-efficacy, and post-traumatic growth. Results: Principal component analysis revealed a one factor solution with excellent internal consistency. Additional construct support offered evidence that higher levels of stigma are related to lower adherence and self-management efficacy, higher levels of anxiety and depressive symptoms, as well as more dissatisfaction with quality of life. Conclusions: This study provides preliminary support for an adapted version of the Reece Stigma Scale, specific to the multiple sclerosis population. The validation data suggests strong psychometric properties. Our findings underscore the clinical importance of measuring and addressing stigma among these patients, with the potential to improve medical (i.e., adherence), psychological (i.e., depression and anxiety), and quality of life outcomes.Implications for rehabilitation Understanding stigma-related experiences is crucial to enhance psychosocial factors related to multiple sclerosis. Stigma-related experiences also impact disease treatment outcomes for individuals with multiple sclerosis. The Reece Stigma Scale is a valid and reliable measure of felt stigma created for use in HIV populations. This study adapted and validated the use of the scale among individuals with multiple sclerosis. Clinicians and researchers working within the rehabilitation and treatment area of multiple sclerosis may benefit from using the adapted Reece Stigma Scale to measure and address stigma experiences.

KW - Multiple sclerosis

KW - assessment

KW - quality of life

KW - stigma

KW - validation

UR - http://www.scopus.com/inward/record.url?scp=85066882212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066882212&partnerID=8YFLogxK

U2 - 10.1080/09638288.2019.1617793

DO - 10.1080/09638288.2019.1617793

M3 - Article

C2 - 31130021

AN - SCOPUS:85066882212

JO - Disability and Rehabilitation

JF - Disability and Rehabilitation

SN - 0963-8288

ER -